Genetic control of antibody production during collagen-induced arthritis development in heterogeneous stock mice

Arthritis and Rheumatism

Volumn 64, Issue 11, 2012, Pages 3594-3603

  Förster, Michael ^a   Raposo, Bruno ^a   Ekman, Diana ^a   Klaczkowska, Dorota ^a   Popovic, Marjan ^a   Nandakumar, Kutty S ^a   Lindvall, Therese ^b   Hultqvist, Malin ^b   Teneva, Ivanka ^b   Johannesson, Martina ^a   Ahlqvist, Emma ^b   Holmdahl, Rikard ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; RHEUMATOID FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTHRITIS; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC REGULATION; IMMUNE RESPONSE; LINKAGE ANALYSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; COLLAGEN TYPE II; DISEASE MODELS, ANIMAL; FEMALE; GENOME-WIDE ASSOCIATION STUDY; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED A; MICE, INBRED AKR; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, INBRED DBA; PEPTIDES, CYCLIC; QUANTITATIVE TRAIT LOCI; RHEUMATOID FACTOR; SPECIES SPECIFICITY;

EID: 84868104226     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34658     Document Type: Article

References (51)

1. Brunsberg U, Gustafsson K, Jansson L, Michaelsson E, Ahrlund-Richter L, Pettersson S, et al. Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur J Immunol 1994; 24: 1698-702.
2. Backlund J, Carlsen S, Hoger T, Holm B, Fugger L, Kihlberg J, et al. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci U S A 2002; 99: 9960-5.
3. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48: 2741-9.
4. Rowley MJ, Nandakumar KS, Holmdahl R,. The role of collagen antibodies in mediating arthritis. Mod Rheumatol 2008; 18: 429-41.
5. Morgan K, Clague RB, Collins I, Ayad S, Phinn SD, Holt PJ,. Incidence of antibodies to native and denatured cartilage collagens (types II, IX, and XI) and to type I collagen in rheumatoid arthritis. Ann Rheum Dis 1987; 46: 902-7.
6. Stuart JM, Dixon FJ,. Serum transfer of collagen-induced arthritis in mice. J Exp Med 1983; 158: 378-92.
7. Wooley PH, Luthra HS, Krco CJ, Stuart JM, David CS,. Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen. Arthritis Rheum 1984; 27: 1010-7.
8. Wooley PH, Luthra HS, Singh SK, Huse AR, Stuart JM, David CS,. Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody. Mayo Clin Proc 1984; 59: 737-43.
9. Nandakumar KS, Svensson L, Holmdahl R,. Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol 2003; 163: 1827-37.
10. Burkhardt H, Koller T, Engstrom A, Nandakumar KS, Turnay J, Kraetsch HG, et al. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. Arthritis Rheum 2002; 46: 2339-48.
11. Kraetsch HG, Unger C, Wernhoff P, Schneider C, Kalden JR, Holmdahl R, et al. Cartilage-specific autoimmunity in rheumatoid arthritis: characterization of a triple helical B cell epitope in the integrin-binding-domain of collagen type II. Eur J Immunol 2001; 31: 1666-73.
12. Nandakumar KS, Holmdahl R,. Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis. J Immunol Methods 2005; 304: 126-36.
13. Burkhardt H, Huffmeier U, Spriewald B, Bohm B, Rau R, Kallert S, et al. Association between protein tyrosine phosphatase 22 variant R620W in conjunction with the HLA-DRB1 shared epitope and humoral autoimmunity to an immunodominant epitope of cartilage-specific type II collagen in early rheumatoid arthritis. Arthritis Rheum 2006; 54: 82-9.
14. Ahlqvist E, Ekman D, Lindvall T, Popovic M, Forster M, Hultqvist M, et al. High-resolution mapping of a complex disease, a model for rheumatoid arthritis, using heterogeneous stock mice. Hum Mol Genet 2011; 20: 3031-41.
15. Johnsen AK, Valdar W, Golden L, Ortiz-Lopez A, Hitzemann R, Flint J, et al. Genome-wide and species-wide dissection of the genetics of arthritis severity in heterogeneous stock mice. Arthritis Rheum 2011; 63: 2630 - 40.
16. Keane TM, Goodstadt L, Danecek P, White MA, Wong K, Yalcin B, et al. Mouse genomic variation and its effect on phenotypes and gene regulation. Nature 2011; 477: 289-94.
17. Wolfowicz CB, Sakorafas P, Rothstein TL, Marshak-Rothstein A,. Oligoclonality of rheumatoid factors arising spontaneously in lpr/lpr mice. Clin Immunol Immunopathol 1988; 46: 382-95.
18. Mott R, Talbot CJ, Turri MG, Collins AC, Flint J,. A method for fine mapping quantitative trait loci in outbred animal stocks. Proc Natl Acad Sci U S A 2000; 97: 12649-54.
19. Valdar W, Holmes CC, Mott R, Flint J,. Mapping in structured populations by resample model averaging. Genetics 2009; 182: 1263-77.
20. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-75.
21. Burkhardt H, Sehnert B, Bockermann R, Engstrom A, Kalden JR, Holmdahl R,. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis. Eur J Immunol 2005; 35: 1643-52.
22. Lindqvist AK, Johannesson M, Johansson AC, Nandakumar KS, Blom AM, Holmdahl R,. Backcross and partial advanced intercross analysis of nonobese diabetic gene-mediated effects on collagen-induced arthritis reveals an interactive effect by two major loci. J Immunol 2006; 177: 3952-9.
23. Johansson AC, Sundler M, Kjellen P, Johannesson M, Cook A, Lindqvist AK, et al. Genetic control of collagen-induced arthritis in a cross with NOD and C57BL/10 mice is dependent on gene regions encoding complement factor 5 and FcγRIIb and is not associated with loci controlling diabetes. Eur J Immunol 2001; 31: 1847-56.
24. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
25. Molina H, Holers VM, Li B, Fung Y, Mariathasan S, Goellner J, et al. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci U S A 1996; 93: 3357-61.
26. Ahearn JM, Fischer MB, Croix D, Goerg S, Ma M, Xia J, et al. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 1996; 4: 251-62.
27. Carroll MC,. The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 1998; 16: 545-68.
28. Applequist SE, Dahlstrom J, Jiang N, Molina H, Heyman B,. Antibody production in mice deficient for complement receptors 1 and 2 can be induced by IgG/Ag and IgE/Ag, but not IgM/Ag complexes. J Immunol 2000; 165: 2398-403.
29. Ferry H, Potter PK, Crockford TL, Nijnik A, Ehrenstein MR, Walport MJ, et al. Increased positive selection of B1 cells and reduced B cell tolerance to intracellular antigens in C1q-deficient mice. J Immunol 2007; 178: 2916-22.
30. Cutler AJ, Cornall RJ, Ferry H, Manderson AP, Botto M, Walport MJ,. Intact B cell tolerance in the absence of the first component of the classical complement pathway. Eur J Immunol 2001; 31: 2087-93.
31. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155-63.
32. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010; 69: 1580-8.
33. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
34. Lopez-Hoyos M, Marquina R, Tamayo E, Gonzalez-Rojas J, Izui S, Merino R, et al. Defects in the regulation of B cell apoptosis are required for the production of citrullinated peptide autoantibodies in mice. Arthritis Rheum 2003; 48: 2353-61.
35. Vossenaar ER, Nijenhuis S, Helsen MM, van der Heijden A, Senshu T, van den Berg WB, et al. Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum 2003; 48: 2489-500.
36. Uysal H, Bockermann R, Nandakumar KS, Sehnert B, Bajtner E, Engstrom A, et al. Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J Exp Med 2009; 206: 449-62.
37. Bajtner E, Nandakumar KS, Engstrom A, Holmdahl R,. Chronic development of collagen-induced arthritis is associated with arthritogenic antibodies against specific epitopes on type II collagen. Arthritis Res Ther 2005; 7: R1148-57.
38. Nandakumar KS, Lindqvist AK, Holmdahl R,. A dominant suppressive MHC class II haplotype interacting with autosomal genes controls autoantibody production and chronicity of arthritis. Ann Rheum Dis 2011; 70: 1664-70.
39. Diaz de Stahl T, Andren M, Martinsson P, Verbeek JS, Kleinau S,. Expression of FcγRIII is required for development of collagen-induced arthritis. Eur J Immunol 2002; 32: 2915-22.
40. Van Lent P, Nabbe KC, Boross P, Blom AB, Roth J, Holthuysen A, et al. The inhibitory receptor FcγRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcγRI/III but also by efficient clearance and endocytosis of immune complexes. Am J Pathol 2003; 163: 1839-48.
41. Kochi Y, Yamada R, Suzuki A, Harley JB, Shirasawa S, Sawada T, et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 2005; 37: 478-85.
42. Lee YH, Woo JH, Choi SJ, Ji JD, Song GG,. Fc receptor-like 3 -169 C/T polymorphism and RA susceptibility: a meta-analysis. Rheumatol Int 2010; 30: 947-53.
43. Stevens TL, Bossie A, Sanders VM, Fernandez-Botran R, Coffman RL, Mosmann TR, et al. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 1988; 334: 255-8.
44. Bandukwala HS, Clay BS, Tong J, Mody PD, Cannon JL, Shilling RA, et al. Signaling through FcγRIII is required for optimal T helper type (Th)2 responses and Th2-mediated airway inflammation. J Exp Med 2007; 204: 1875-89.
45. Hjelm F, Carlsson F, Getahun A, Heyman B,. Antibody-mediated regulation of the immune response. Scand J Immunol 2006; 64: 177-84.
46. Nimmerjahn F, Ravetch JV,. Divergent immunoglobulin G subclass activity through selective Fc receptor binding. Science 2005; 310: 1510-2.
47. Gavin AL, Barnes N, Dijstelbloem HM, Hogarth PM,. Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity. J Immunol 1998; 160: 20-3.
48. Hjelm F, Carlsson F, Verbeek S, Heyman B,. IgG3-mediated enhancement of the antibody response is normal in FcγRI-deficient mice. Scand J Immunol 2005; 62: 453-61.
49. Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N Engl J Med 2007; 357: 1199-209.
50. Grant EP, Picarella D, Burwell T, Delaney T, Croci A, Avitahl N, et al. Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis. J Exp Med 2002; 196: 1461-71.
51. Hietala MA, Nandakumar KS, Persson L, Fahlen S, Holmdahl R, Pekna M,. Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis. Eur J Immunol 2004; 34: 1208-16.